SOA Wealth Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$130K Buy
1,028
+6
+0.6% +$791 0.02% 258
2026
Q1
$142K Buy
1,022
+6
+0.6% +$840 0.03% 237
2025
Q4
$125K Buy
1,016
+81
+9% +$9.84K 0.02% 258
2025
Q3
$104K Buy
935
+7
+0.8% +$796 0.02% 287
2025
Q2
$103K Sell
928
-330
-26% -$35.1K 0.02% 276
2025
Q1
$141K Buy
1,258
+307
+32% +$31.7K 0.03% 223
2024
Q4
$87.9K Buy
951
+5
+0.5% +$450 0.02% 263
2024
Q3
$79.3K Buy
946
+8
+0.9% +$610 0.02% 269
2024
Q2
$64.3K Buy
938
+4
+0.4% +$267 0.01% 283
2024
Q1
$68.4K Buy
934
+82
+10% +$6.31K 0.01% 275
2023
Q4
$69K Buy
852
+8
+0.9% +$623 0.02% 268
2023
Q3
$63.3K Buy
844
+8
+1% +$615 0.02% 261
2023
Q2
$64.5K Buy
836
+7
+0.8% +$558 0.02% 268
2023
Q1
$68.8K Buy
829
+7
+0.9% +$580 0.02% 253
2022
Q4
$70.5K Sell
822
-5
-0.6% -$396 0.02% 247
2022
Q3
$51K Buy
827
+8
+1% +$504 0.02% 262
2022
Q2
$50K Sell
819
-413
-34% -$25.6K 0.01% 264
2022
Q1
$73K Buy
1,232
+17
+1% +$1.09K 0.02% 265
2021
Q4
$89K Hold
1,215
0.02% 232
2021
Q3
$84K Buy
1,215
+8
+0.7% +$562 0.02% 243
2021
Q2
$83K Buy
1,207
+286
+31% +$19.1K 0.02% 245
2021
Q1
$59K Sell
921
-78
-8% -$5.03K 0.02% 252
2020
Q4
$67K Buy
+999
New +$60.3K 0.02% 233

Other funds holding GILD

SOA Wealth Advisors's GILD Position: Q2 2026 in Review

SOA Wealth Advisors increased its Gilead Sciences (GILD) stake by 0.59% in Q2 2026, buying an estimated $791 and bringing the position to 1,028 shares worth $130K. The position accounts for 0.02% of the portfolio, ranked #258.

SOA Wealth Advisors first reported a position in GILD in Q4 2020 and has held it in 23 quarters since. The position peaked at $142K in Q1 2026. 486 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • SOA Wealth Advisors held 1,028 shares of Gilead Sciences worth $130K as of Q2 2026.
  • SOA Wealth Advisors bought 6 Gilead Sciences shares in Q2 2026, an estimated $791.
  • Gilead Sciences made up 0.02% of SOA Wealth Advisors's portfolio in Q2 2026, its #258 holding.
  • SOA Wealth Advisors first reported a position in Gilead Sciences in Q4 2020 and has held it in 23 quarters since.
  • SOA Wealth Advisors's Gilead Sciences position peaked at $142K in Q1 2026.
  • 486 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on SOA Wealth Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.